All Type of News
Practitioners protest oriental medicine insurance
Practitioners of traditional oriental medicine have expressed their opposition to an agreement that has recently reached between the government and the Association of Korean Medicine (AKM) to apply national health ins...
Cataract operations claim top spot on 2011 surgery list
Cataracts were the most frequently cited illness causing Koreans to head to the surgery room last year, the National Health Insurance Corp. (NHIC) said Sunday.
A total of 1.65 million individuals received one of 33...
Lee to head hospital pharmacists groupLee Kwang-sup, drug dispensing manager of Konkuk University Medical Center, was elected the 22th chairman of the Korean Hospital Pharmacist Association, last Friday at President...
|
Myungmoon denies Teva’s takeover
Myungmoon Pharm Thursday dismissed the report of M&A (merger and acquisition) with Israel’s generic giant Teva Pharmaceutical Industries.
Ahn Do-gul, a ministry official of Health and Welfare, said Wednesday that T...
Myungmoon shares showing steep rally
Myungmoon Pharm’s shares showed steep rally Wednesday and Thursday following the report that Israel’s generic giant Teva Pharmaceutical Industries would acquire a controlling in the Korean firm.
Alvogen has recentl...
KFDA to standardize names of 2,940 active ingredients
The descriptions of 2,940 active ingredients will be standardized to avoid that they are misunderstood as other chemical substances in the screening process for approval, according to the Korea Food and Drug Administr...
37 drug makers spend 10% of revenue in 2011
Korea’s 37 pharmaceutical firms spared 9.6 percent of their annual revenue on research and development (R&D) of new medicine last year, up 12.1 percent from a year earlier, a poll showed Thursday.
A survey released...
Bill calling for establishment of non-profit hospitals in free economic zones
A lawmaker Tuesday proposed a bill to allow non-profit foreign hospitals to operate in the free economic zone (FEZ)
The bill, proposed by Rep. Kim Yong-ik of the main oppsition Democratic United Party is designed t...
Pfizer Korea wins Lyrica patent suit
The Korean Intellectual Property Tribunal has ruled in favor of Pfizer Korea in a patent nullification suit involving Pfizer’s use patent covering Lyrica (pregabalin).
Lyrica is used to treat chronic pain disorders...
CJ to appeal against to Lyrica ruling
CJ Pharm said Wednesday that it will appeal against the latest ruling by Korean Intellectual Property Tribunal that favored Pfizer Korea over the nullification trial of Pfizer’s use patent covering Lyrica (pregabalin)...
